We are Sorry, This Page doesn't Exist
Ionis shares tumble 19% after Roche halts Phase 3 study for rare-disease drug
Shares of Ionis Pharmaceuticals Inc. were down 19.6% in premarket trading on Tuesday, the day after the company said Roche Holding AG decided to discontinue.....»»
Immunic Gets Bullish Rating On Multiple Sclerosis Drug Prospect
Immunic Inc’s (NASDAQ: IMUX) lead candidate, IMU-838, has an “attractive safety profile” and exhibited positive efficacy results in the Phase II trials, according to JMP Securities. read more.....»»
BrainStorm reports "positive" data in Phase 2 study evaluating NurOwn
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Myovant Sciences, Pfizer report "positive" results from Phase 3 Liberty study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Pfizer starts early-stage study of oral COVID-19 treatment
Shares of Pfizer Inc. were down 1.1% in trading on Tuesday after the drug maker said it initiated a Phase 1 cl.....»»
Alnylam to present full 9-month results from HELIOS-A Phase 3 study at AAN
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Ionis shares tumble19% after Roche halts Phase 3 study for rare-disease drug
Shares of Ionis Pharmaceuticals Inc. were down 19.6% in premarket trading on Tuesday, the day after the company said Roche Holding AG decided to discontinue.....»»
Equinox Gold: Positive feasibility study for Castle Mountain Phase 2 expansion
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Gilead, Galapagos drug fails in Phase 3 clinical study
Shares of Gilead Sciences Inc. were down 0.1% in premarket trading on Thursday, the day after the company said an experimental idiopathic pulmonary fibrosis drug it was developing with Galapagos failed a Phase 3 clinical trial. Shares o.....»»
Atossa Therapeutics halts Phase 2 Endoxifen study after "positive" results
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
BiomX announces "positive" results from Phase 1a pharmacokinetic study of BX002
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
PhaseBio patients completed Phase 1b/2a study of PB1046 with no drug-related SEs
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Sorrento reports "positive" preliminary results of Phase 1b COVID-MSC study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Myovant Sciences, Pfizer report "positive" results from Phase 3 SPIRIT study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Biogen"s stock is up 5% after Lilly reports positive data from an Alzheimer"s study
Shares of Biogen Inc. gained 5.6% in trading on Monday after another drugmaker shared positive clinical data about an experimental Alzheimer's disease treatment that is similar to a Biogen therapy under review by the Food and Drug A.....»»
Supernus stock surges after ADHD-drug study results
Supernus Pharmaceuticals Inc. shares jumped more than 20% in after-hours trading Tuesday after the company revealed positive .....»»
Veru"s stock soars again on heavy volume after positive results of breast cancer treatment
Shares of Veru Inc. soared 51.4% toward a seven-year high on massive volume, after the biopharmaceutical company announced positive results from a Phase 2 study of its treatment.....»»
Pfizer announces "positive" results from Phase 3 pneumococcal vaccine study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Raleigh pharma to study coronavirus treatment on patients in U.S.
A Triangle drugmaker that's seen positive results with its Covid-19 treatment internationally can now start treating patients in the U.S. Raleigh's RedHill Biopharma (Nasdaq: RDHL) has received approval from the U.S. Food and Drug Administration .....»»
Akebia Shares Climb on Positive Anemia Drug Study Results
Company hits 52-week high of $12.25Related Stocks: AKBA, AMGN, FGEN, GSK, OTSKY, MTZPY,.....»»